摘要手术切除是唯一有可能治愈结直肠癌肝转移（CRLM）的方法。CRLM同期机器人切除可使患者免受前后两次手术的痛苦，具有切口小、恢复快、住院时间短、术后早期即可行化疗等优势。相对腹腔镜手术，同期机器人切除尤其适用于直肠癌肝转移，手术中转率低、自主神经保护好，大范围及困难部位肝切除成功率高。选择适宜的患者、强调多学科合作以及由具备丰富机器人手术经验的医生精细操作是成功的关键。现有的数据表明，CRLM同期机器人切除安全可行。相信随着高级别前瞻性随机对照研究数据的积累及机器人手术系统的变革，CRLM同期机器人切除前景令人期待。

abstractsSurgical resection remains the only curative therapy for colorectal adenocarcinoma and liver metastasis. Synchronous robotic resection for colorectal liver metastasis (CRLM) offers the advantage of avoiding double surgical stress, while providing the benefits of small incision, quicker recovery, shorter hospital stay and faster postoperative adjuvant therapy. Compared with the laparoscopic approach, robotic approach is mostly suitable for rectal cancer liver metastasis, which is associated with low conversion rate, good nerve protection, high success rate for major hepatectomy and resection of difficult segments. Appropriately selected patients, multidisciplinary cooperation and skillful robotic surgeons are the key to success. Current data have demonstrated the feasibility and safety of synchronous robotic resection for CRLM. With the coming randomized controlled trial data and evolution of robotic surgical system, the future of synchronous robotic resection for colorectal liver metastasis is promising.